MUCET -C

COMPOSITION: LEVOCETERIZINE 2.5 MG PHENYLPHERINE HCL 5 MG AMBROXOL 60 MG PARACETAMOL 325 MG

Categories: , Tag:
  • Reviews (0)
  • Indications
  • Product Description

Reviews

There are no reviews yet.


Be the first to review “MUCET -C”

Seasonal and Perennial Allergic Rhinitis and Urticaria.

 

Levocetirizine :
levocetirizine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose. Levocetirizine Hcl works by blocking the actions of histamine. Levocetirizine Hcl is used to treat symptoms of perennial allergies in adults and children who are at least 6 months old. Levocetirizine Hcl is also used to treat symptoms of seasonal allergies in adults and children who are at least 2 years old and it is also used to treat itching and swelling caused by chronic urticaria (hives) in adults and children who are at least 6 months old.

Pharmacokinetics
Absorption: Rapidly and extensively absorbed. T max is 0.9 h. C max is 270 and 308 ng/mL after single and repeated once-daily dosing, respectively. Steady state achieved after 2 days.
Distribution: Plasma protein binding about 92%. Vd is approximately 0.4 L/kg.
Metabolism: Metabolism is less than 14% and by aromatic oxidation, N- and Odealkylation, and taurine conjugation.
Elimination: The t ½ is about 8 to 9 h. Elimination is 85.4% and 12.9% via urine and feces, respectively. Excreted both by glomerular filtration and active tubular transport.

Mechanism
The active component of Levocetirizine dihydrochloride, is the R enantiomer of cetirizine hydrochloride, a racemic compound with antihistaminic properties. It is an orally active and selective H1-receptor antagonist. Histamines act on H1 receptors, causing the symptoms commonly seen in allergic reactions. Its inhibits these H1 receptors.

Interactions
Like cetirizine, levocetirizine is to a high degree excreted unchanged: less than 14% of a given dose is converted into metabolites. There are several different metabolic pathways, including through the CYP1A2, 2C9, 2C19, 2D6, 2E1 and 3A4t pathways in the liver. A total of 13 different metabolites have been observed. In vitro studies have shown that levocetirizine does not affect the CYP isoenzymes of the liver, and the risk of interactions in connection with metabolism is considered to be very low.
There is a risk of interaction if the drug is used concurrently with alcohol or other CNS depressants.

Side Effects
The most commonly reported adverse effects are:
Sleepiness
Dizziness
Dry Mouth